Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge

Procedia in Vaccinology

Volumn 2, Issue 1, 2010, Pages 73-77

  Whitlock, Gregory C ^a,b   Deeraksa, Arpaporn ^a   Qazi, Omar ^c   Judy, Barbara M ^a   Taylor, Katherine ^a   Propst, Katie L ^e   Duffy, Angie J ^e   Johnson, Kate ^c   Kitto, G Barrie ^c   Brown, Katherine A ^c,d   Dow, Steven W ^e   Torres, Alfredo G ^a   Estes, D Mark ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Texas Medical Branch ^*  (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Bordetella pertussis; BPZE1; BrkA autotransporter; Enterovirus 71; Live mucosal vaccine

Indexed keywords

ABC TRANSPORTER; BACTERIAL DNA; BACTERIAL PROTEIN; BACTERIAL VACCINE; BIM PROTEIN; BOVINE SERUM ALBUMIN; BURKHOLDERIA MALLEI RECOMBINANT PROTEIN BIMA; BURKHOLDERIA MALLEI RECOMBINANT PROTEIN BOPA; BURKHOLDERIA MALLEI RECOMBINANT PROTEIN HCP 1; BURKHOLDERIA PSEUDOMALLEI RECOMBINANT PROTEIN LO 1C; CPG OLIGODEOXYNUCLEOTIDE; CPG OLIGODEOXYNUCLEOTIDE 2395; GAMMA INTERFERON; GENOMIC DNA; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOLOGICAL ADJUVANT; ISCOM; PLASMID DNA; RECOMBINANT PROTEIN; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; BACTERIAL IMMUNITY; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG MIXTURE; FEMALE; GLANDERS; INFECTION PREVENTION; MELIOIDOSIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SURVIVAL; T LYMPHOCYTE; VACCINATION; VACCINE PRODUCTION;

EID: 77950660656     PISSN: 1877282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.provac.2010.03.013     Document Type: Conference Paper

References (24)

1. Neubauer H., Sprague L.D., Zacharia R., Tomaso H., Al Dahouk S., Wernery R., et al. Serodiagnosis of Burkholderia mallei infections in horses: state-of-the-art and perspectives. Journal of Veterinary Medicine Series B 52 (2005) 201-205
2. Srinivasan A, Kraus CN, DeShazer D, Becker PM, D. DJ, Spacek L, et al. 2001. Glanders in a military research microbiologist, N Engl J Med 345 256-258.
3. Dance D.A.B. Melioidosis - the tip of the iceberg. Clin Microbiol Rev 4 (1991) 52-60
4. Stone R. Infectious disease. Racing to defuse a bacterial time bomb. Science 317 (2007) 1022-1024
5. Horn J.K. Bacterial agents used for bioterrorism. Surgical Infections 4 (2003) 281-287
6. Nelson M., Prior J.L., Lever M.S., Jones H.E., Atkins T.P., Titball R.W., et al. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J Med Microbiol 53 (2004) 1177-1182
7. Brett P., Mah D., and Woods D. Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect Immun 62 (1994) 1914-1919
8. Brett P.J., and Woods D.E. Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect Immun. 64 (1996) 2824-2828
9. Bryan L.E., Wong S.E., Woods D., Dance D., and Chaowagul W. Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis. 5 (1994) 170-178
10. Whitlock G.C., Estes D.M., and Torres A.G. Glanders: off to the races with Burkholderia. FEMS Microbiol. Lett. 277 (2007) 115-122
11. Whitlock G.C., Estes D.M., Young G.M., Young B., and Torres A.G. Construction of a reporter system to study Burkholderia mallei type III secretion and identification of the BopA effector protein function in intracellular survival. Transactions of the Royal Society of Tropical Medicine & Hygiene 102 Suppl 1 (2008) S127-S133
12. Bendtsen J.D., von Heijne G., Brunak S., Bendtsen J.D., Nielsen H., et al. Improved prediction of signal peptides: SignalP 3.0. Journal of Molecular Biology 340 (2004) 783-795
13. Krogh A., Larsson B., von Heijne G., and Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. Journal of Molecular Biology 305 (2001) 567-580
14. Kelley L.A., Sternberg M.J., Kelley L.A., and Sternberg M.J.E. Protein structure prediction on the Web: a case study using the Phyre server. Nature Protocols 4 (2009) 363-371
15. Harland D.N., Chu K., Haque A., Nelson M., Walker N.J., Sarkar-Tyson M., et al. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Infection & Immunity 75 (2007) 4173-4180
16. Zaks K., Jordan M., Guth A., Sellins K., Kedl R., Izzo A., et al. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J Immunol. 176 (2006) 7335-7345
17. Goodyear A., Kellihan L., Bielefeldt-Ohmann H., Troyer R., Propst K., Dow S., et al. Protection from pneumonic infection with burkholderiaBurkholderia species by inhalational immunotherapy. Infection & Immunity 77 (2009) 1579-1588
18. Chen Y.-S., Hsiao Y.-S., Lin H.-H., Liu Y., and Chen Y.-L. CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice. Infection & Immunity 74 (2006) 1699-1705
19. Elvin S.J., Healey G.D., Westwood A., Knight S.C., Eyles J.E., and Williamson E.D. Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization. Infection & Immunity 74 (2006) 1706-1711
20. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nature Reviews Drug Discovery 5 (2006) 471-484
21. Utaisincharoen P., Kespichayawattana W., Anuntagool N., Chaisuriya P., Pichyangkul S., Krieg A.M., et al. CpG ODN enhances uptake of bacteria by mouse macrophages. Clinical & Experimental Immunology 132 (2003) 70-75
22. Vollmer J., and Krieg A.M. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Advanced Drug Delivery Reviews 61 (2009) 195-204
23. Waag D.M., McCluskie M.J., Zhang N., and Krieg A.M. A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei. Infection & Immunity 74 (2006) 1944-1948
24. Wongratanacheewin S., Kespichayawattana W., Intachote P., Pichyangkul S., Sermswan R.W., Krieg A.M., et al. Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei. Infection & Immunity 72 (2004) 4494-4502